Med 10.02(2)(e)
(e) Giving, selling, buying, bartering, or attempting to give, sell, buy, or barter any license.
Med 10.02(2)(f)
(f) Engaging or attempting to engage in practice under any license under any given name or surname other than that under which originally licensed or registered to practice in this or any other state. This subsection does not apply to change of name resulting from marriage, divorce, or order by a court of record.
Med 10.02(2)(g)
(g) Engaging or attempting to engage in the unlawful practice of medicine and surgery or treating the sick.
Med 10.02(2)(h)
(h) Any practice or conduct which tends to constitute a danger to the health, welfare, or safety of patient or public.
Med 10.02(2)(i)
(i) Practicing or attempting to practice under any license when unable to do so with reasonable skill and safety to patients.
Med 10.02(2)(j)
(j) Practicing or attempting to practice under any license beyond the scope of that license.
Med 10.02(2)(k)
(k) Offering, undertaking, or agreeing to treat or cure a disease or condition by a secret means, method, device, or instrumentality; or refusing to divulge to the board upon demand the means, method, device, or instrumentality used in the treatment of a disease or condition.
Med 10.02(2)(L)
(L) Representing that a manifestly incurable disease or condition can be or will be permanently cured; or that a curable disease or condition can be cured within a stated time, if such is not the fact.
Med 10.02(2)(m)
(m) Knowingly making any false statement, written or oral, in practicing under any license, with fraudulent intent; or obtaining or attempting to obtain any professional fee or compensation of any form by fraud or deceit.
Med 10.02(2)(n)
(n) Willfully divulging a privileged communication or confidence entrusted by a patient or deficiencies in the character of patients observed in the course of professional attendance, unless lawfully required to do so.
Med 10.02(2)(o)
(o) Engaging in uninvited, in-person solicitation of actual or potential patients who, because of their particular circumstances, are vulnerable to undue influence; or engaging in false, misleading or deceptive advertising.
Med 10.02(2)(p)
(p) Administering, dispensing, prescribing, supplying, or obtaining controlled substances as defined in s.
961.01 (4), Stats., otherwise than in the course of legitimate professional practice, or as otherwise prohibited by law.
Med 10.02(2)(q)
(q) Having a license, certificate, permit, registration, or other practice credential granted by another state or by any agency of the federal government to practice medicine and surgery or treat the sick, which becomes limited, restricted, suspended, or revoked, or having been subject to other adverse action by the state licensing authority or by any agency of the federal government, including but not limited to the denial or limitation of an original credential, or the surrender of a credential, whether or not accompanied by findings of negligence or unprofessional conduct.
Med 10.02(2)(r)
(r) Conviction of any crime which may relate to practice under any license, or of violation of any federal or state law regulating the possession, distribution, or use of controlled substances as defined in s.
961.01 (4), Stats. A certified copy of a judgment of a court of record showing such conviction, within this state or without, shall be presumptive evidence thereof.
Med 10.02(2)(s)
(s) Prescribing, ordering, dispensing, administering, supplying, selling, or giving any amphetamine or sympathomimetic amine drug designated as a schedule II controlled substance to or for any person except for any of the following:
Med 10.02(2)(s)1.
1. Use as an adjunct to opioid analgesic compounds for treatment of cancer-related pain,
Med 10.02(2)(s)7.
7. Treatment of depression shown to be refractory to other therapeutic modalities,
Med 10.02(2)(s)8.
8. Clinical investigation of the effects of such drugs or compounds in which case an investigative protocol therefore shall have been submitted to and reviewed and approved by the board before such investigation has been begun.
Med 10.02(2)(t)
(t) Aiding or abetting the unlicensed practice of medicine or representing that unlicensed persons practicing under supervision, including unlicensed M.D.'s and D.O's, are licensed, by failing to identify the individuals clearly as unlicensed physicians or delegates.
Med 10.02(2)(u)
(u) Failure to inform a patient about the availability of all alternate, viable medical modes of treatment and about the benefits and risks of these treatments, including the benefits and risks associated with the use of extended wear contact lenses.
Med 10.02(2)(w)
(w) Use in advertising of the term "board certified" or a similar phrase of like meaning unless in fact so certified and unless disclosure is made of the complete name of the speciality board which conferred the certification.
Med 10.02(2)(x)
(x) Prescribing, ordering, dispensing, administering, supplying, selling or giving any anabolic steroid for the purposes of enhancing athletic performance or for other nonmedical purposes.
Med 10.02(2)(z)
(z) Violating or aiding and abetting the violation of any law or administrative rule or regulation the circumstances of which substantially relate to the circumstances of the practice of medicine.
Med 10.02(2)(za)
(za) Failure by a physician or physician assistant to maintain patient health care records consistent with the requirements of
ch. Med 21.
Med 10.02(2)(zb)
(zb) Prescribing, ordering, dispensing, administering, supplying, selling or giving any anorectic drug designated as a schedule III, IV or V controlled substance for the purpose of weight reduction or control in the treatment of obesity unless each of the following conditions is met:
Med 10.02(2)(zb)1.
1. The patient's body mass index, weight in kilograms divided by height in meters squared, is greater than 25.
Med 10.02(2)(zb)2.
2. A comprehensive history, physical examination, and interpreted electrocardiogram are performed and recorded at the time of initiation of treatment for obesity by the prescribing physician.
Med 10.02(2)(zb)3.
3. A diet and exercise program for weight loss is prescribed and recorded.
Med 10.02(2)(zb)4.
4. The patient is weighed at least once a month, at which time a recording is made of blood pressure, pulse, and any other tests as may be necessary for monitoring potential adverse effects of drug therapy.
Med 10.02(2)(zb)5.
5. No more than a 30-day supply of drugs is prescribed or dispensed at any one time.
Med 10.02(2)(zb)6.
6. No drugs are prescribed or dispensed for more than 90 days unless all of the following occur:
Med 10.02(2)(zb)6.a.
a. The patient has a recorded weight loss of at least 12 pounds in the first 90 days of therapy.
Med 10.02(2)(zb)6.b.
b. The patient has continued progress toward achieving or maintaining a target weight.
Med 10.02(2)(zb)7.
7. Any variance from the foregoing requirements is justified by documentation in the patient's record.
Med 10.02(2)(zc)
(zc) After a request by the board, failing to cooperate in a timely manner with the board's investigation of a complaint filed against the credential holder. There is a rebuttable presumption that a credential holder who takes longer than 30 days to respond to a request of the board has not acted in a timely manner.
Med 10.02(2)(zd)
(zd) Engaging in inappropriate sexual contact, exposure, gratification, or other sexual behavior with or in the presence of a patient. For the purposes of this subsection, an adult receiving treatment shall continue to be a patient for 2 years after the termination of professional services. If the person receiving treatment is a minor, the person shall continue to be a patient for the purposes of this subsection for 2 years after termination of services, or for 2 years after the patient reaches the age of majority, whichever is longer.
Med 10.02 History
History: Cr.
Register, October, 1976, No. 250, eff. 11-1-76; cr. (2)(s),
Register, October, 1977, No. 262, eff. 11-1-77; am. (2) (m),
Register, April, 1978, No. 268, eff. 5-1-78; am. (2) (s),
Register, May, 1978, No. 269, eff. 6-1-78; reprinted to correct History note,
Register, June, 1980, No. 294; r. and recr. (2) (o), cr. (2) (t),
Register, September, 1985, No. 357, eff. 10-1-85; cr. (2) (u),
Register, April, 1987, No. 376, eff. 5-1-87; cr. (2) (v),
Register, January, 1988, No. 385, eff. 2-1-88; am. (2) (s),
Register, March, 1990, No. 411, eff. 3-1-90; cr. (2) (x),
Register, September, 1990, No. 417, eff. 10-1-90; cr. (2) (w),
Register, October, 1990, No. 418, eff. 11-1-90; am. (2) (q),
Register, August, 1992, No. 440, eff. 9-1-92; cr. (2) (y),
Register, September, 1992, No. 441, eff. 10-1-92; cr. (2) (z),
Register, May, 1995, No. 473, eff. 6-1-95; cr. (2) (za),
Register, April, 1996, No. 484, eff. 5-1-96; am. (2) (q),
Register, September, 1996, No. 489, eff. 10-1-96; corrections made under s. 13.93 (2m) (b) 7., Stats.,
Register, February, 1997, No. 494; cr. (2) (zb),
Register, May, 1998, No. 509, eff. 6-1-98; r. (2) (v) and (y), am. (2) (za),
Register, December, 1999, No. 528, eff. 1-1-00;
CR 01-031: am. (2) (s) (intro.) and (zb) (intro.),
Register October 2001 No. 550, eff. 11-1-01;
CR 02-008: cr. (2) (zc),
CR 02-055: cr. (2) (zd),
Register November 2002 No. 563, eff. 12-1-02.
